![](/img/cover-not-exists.png)
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation
Gouynou, Célia, Pouillon, Lieven, Rousseau, Hélène, Zallot, Camille, Baumann, Cédric, Peyrin-Biroulet, LaurentLanguage:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2017-315766
Date:
January, 2018
File:
PDF, 427 KB
english, 2018